Citadel Advisors’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,948
| Closed | -$42.3K | – | 5996 |
|
|
2024
Q4 | $42.3K | Buy |
+3,948
| New | +$42.3K | ﹤0.01% | 5497 |
|
|
2024
Q3 | – | Sell |
-118,376
| Closed | -$1.78M | – | 5850 |
|
|
2024
Q2 | $1.78M | Sell |
118,376
-2,410
| -2% | -$36.2K | ﹤0.01% | 2555 |
|
|
2024
Q1 | $3.38M | Sell |
120,786
-2,162
| -2% | -$60.5K | ﹤0.01% | 2059 |
|
|
2023
Q4 | $2.75M | Sell |
122,948
-19,734
| -14% | -$442K | ﹤0.01% | 2138 |
|
|
2023
Q3 | $2.97M | Sell |
142,682
-6,625
| -4% | -$138K | ﹤0.01% | 2039 |
|
|
2023
Q2 | $3.82M | Buy |
149,307
+7,385
| +5% | +$189K | ﹤0.01% | 1897 |
|
|
2023
Q1 | $3.95M | Buy |
141,922
+4,314
| +3% | +$120K | ﹤0.01% | 1993 |
|
|
2022
Q4 | $3.58M | Buy |
137,608
+6
| +0% | +$156 | ﹤0.01% | 2092 |
|
|
2022
Q3 | $4.07M | Sell |
137,602
-164
| -0.1% | -$4.85K | ﹤0.01% | 2044 |
|
|
2022
Q2 | $5.62M | Buy |
137,766
+158
| +0.1% | +$6.45K | ﹤0.01% | 1754 |
|
|
2022
Q1 | $7.54M | Sell |
137,608
-3,010
| -2% | -$165K | ﹤0.01% | 1677 |
|
|
2021
Q4 | $13.8M | Sell |
140,618
-3,368
| -2% | -$330K | ﹤0.01% | 1196 |
|
|
2021
Q3 | $36.4M | Sell |
143,986
-4,022
| -3% | -$1.02M | 0.01% | 580 |
|
|
2021
Q2 | $44.9M | Buy |
148,008
+1,838
| +1% | +$557K | 0.01% | 548 |
|
|
2021
Q1 | $96.2M | Buy |
+146,170
| New | +$96.2M | 0.02% | 227 |
|